1. "General Medicine Services"
  2. "Surgery"
  3. "Michael Berger"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (15)
  2. GSK Faculty (15)
  3. General Medicine Services (15)
  4. Human Oncology and Pathogenesis Program (15)
  5. Solid Tumor Oncology Division (15)
  6. Surgery (15)

More Groups

People
  1. Michael Berger (15)
  2. Zsofia Stadler (12)
  3. Alicia Latham (10)
  4. David Solit (10)
  5. Diana Mandelker (10)
  6. Kenneth Offit (10)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (3)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (2)
  3. Annals of Oncology (1)
  4. Cancer Discovery (1)
  5. Cancer Epidemiology Biomarkers and Prevention (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (3)
  3. Oxford University Press (2)
  4. Wiley Blackwell (2)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in patients with endometrial cancer of diverse ancestry
    Journal Article

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcomas
    Journal Article

    Sia, T. Y.; Gordhandas, S. B.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M. L.; Rubinstein, M.; Makker, V.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants
    Journal Article

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Arnold, A. G.; Fleischut, M. H.; Latham, A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of DNA mismatch repair-deficient small bowel adenocarcinoma
    Journal Article

    Latham, A.; Shia, J.; Patel, Z.; Reidy-Lagunes, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L.; Kemeny, N. E.; Kelsen, D. P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save